Ceres Pharma

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-11-20",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-11-28",
    "filing_date": "2025-11-26",
    "act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), KAPITAAL, AANDELEN"
  },
  "decision": {
    "body": "notarieel_alleen",
    "act_date": "2024-05-13",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "other"
    ],
    "scope": null,
    "trigger": null,
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full_after": "Ceres Pharma",
    "legal_form_after": "Naamloze vennootschap",
    "name_full_before": "Ceres Pharma",
    "current_zetel_raw": "Kortrijksesteenweg 1091 bus B",
    "legal_form_before": "Naamloze vennootschap"
  },
  "special_mandates": [],
  "articles_modified": [],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Tim CARNEWAL",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "een uitgifte van de akte",
    "de geco\u00F6rdineerde tekst van statuten"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_kind"
    ],
    "split_ratio": null,
    "shares_after": 167917449,
    "shares_before": null,
    "capital_after_eur": 50375234.71,
    "capital_before_eur": null,
    "share_classes_after": []
  },
  "coordinated_text_lineage": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma"
  },
  "legal_form_change": {
    "new": "",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 50375234.71,
      "currency": "EUR",
      "after_eur": 50375234.71,
      "delta_eur": 50375234.71,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-05-13",
      "evidence_quote": "De vergadering stelt vast en verzoekt ons, notaris, akte te nemen van het feit dat de voormelde kapitaalverhoging daadwerkelijk verwezenlijkt werd en dat het kapitaal aldus daadwerkelijk gebracht werd op EUR 50.375.234,71",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 167917449,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-11-28",
    "filing_date": "2025-11-26",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2024-05-13",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": null,
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "een uitgifte van de akte",
    "de geco\u00F6rdineerde tekst van statuten"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 50375234.71,
      "delta_eur": null,
      "before_eur": null,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Wouter Coppens",
        "address": null,
        "birth_date": null,
        "profession": "bedrijfsrevisor",
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "PwC Bedrijfsrevisoren BV",
        "address": "Culliganlaan 5, 1831 Diegem",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2023-07-01",
      "evidence_quote": "De Firma PwC Bedrijfsrevisoren zal vanaf 1 juli 2023 vertegenwoordigd worden door de heer Wouter Coppens, in de uitoefening van zijn mandaat van Commissaris, ter vervanging van de heer Peter Opsomer.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 3
      },
      "rep_rotation_new_rep": "Wouter Coppens",
      "rep_rotation_old_rep": "Peter Opsomer",
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Wouter Coppens",
        "address": null,
        "birth_date": null,
        "profession": "bedrijfsrevisor",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "PwC Bedrijfsrevisoren BV",
        "address": "Culliganlaan 5, 1831 Diegem",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Deze vennootschap wijst overeenkomstig artikel 3:60 WVV Wouter Coppens BV, aan, voor de uitoefening van het mandaat, met als vaste vertegenwoordiger Wouter Coppens, bedrijfsrevisor.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Peter Opsomer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "mandate_termination_de_plein_droit",
      "role": "commissaris",
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Het mandaat vervalt na de algemene vergadering die de jaarrekening per 31 december 2025 dient goed te keuren",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": 2025
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2025-08-07",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2023-06-23",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma NV",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Mario Debel",
    "org_rep_person_name": null,
    "person_role_at_subject": "Aandeelhouder/Bestuurder"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Wouter Coppens",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "PwC Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-07-01",
      "evidence_quote": "De algemene vergadering benoemt PwC Bedrijfsrevisoren BV, met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, als commissaris voor een termijn van drie jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "Commissaris",
      "person": {
        "rrn": null,
        "name": "Wouter Coppens",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Commissaris",
      "person": {
        "rrn": null,
        "name": "Peter Opsomer",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Wouter Coppens",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0641953324",
        "name": "PwC Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-07-01",
      "evidence_quote": "De firma PwC Bedrijfsrevisoren BV zal vanaf 1 juli 2023 vertegenwoordigd worden door de heer Wouter Coppens, in de uitoefening van zijn mandaat van commissaris, ter vervanging van de heer Peter Opsomer."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Wouter Coppens",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Peter Opsomer",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Wouter Coppens",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2023-07-01",
      "evidence_quote": "De firma PwC Bedrijfsrevisoren BV zal vanaf 1 juli 2023 vertegenwoordigd worden door de heer Wouter Coppens, in de uitoefening van zijn mandaat van commissaris, ter vervanging van de heer Peter Opsomer.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": "Wouter Coppens",
      "rep_rotation_old_rep": "Peter Opsomer",
      "effective_date_qualifier": null
    },
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Peter Opsomer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2023-07-01",
      "evidence_quote": "De firma PwC Bedrijfsrevisoren BV zal vanaf 1 juli 2023 vertegenwoordigd worden door de heer Wouter Coppens, in de uitoefening van zijn mandaat van commissaris, ter vervanging van de heer Peter Opsomer.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Wouter Coppens",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Peter Opsomer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Mario Debel",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Ceres Invest BV",
        "address": null,
        "country": null,
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-09-03",
    "filing_date": "2024-08-23",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2023-06-23",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Mario Debel",
    "org_rep_person_name": null,
    "person_role_at_subject": "Aandeelhouder/Bestuurder"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma"
  },
  "legal_form_change": {
    "new": "Naamloze vennootschap",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 50375234.71,
      "delta_eur": 4608796.87,
      "before_eur": 45766437.84,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 15362656,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 0.3
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-05-27",
    "filing_date": "2024-05-23",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-05-13",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "PwC Bedrijfsrevisoren BV",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Wouter Coppens"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "uitgifte van het proces-verbaal",
    "volmacht",
    "de geco\u00F6rdineerde tekst van statuten",
    "het verslag van het bestuursorgaan",
    "het verslag van de commissaris"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 4608796.87,
      "currency": "EUR",
      "after_eur": 50375234.71,
      "delta_eur": 4608796.87,
      "before_eur": 45766437.84,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-05-13",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van EUR 4.608.796,87, om het van EUR 45.766.437,84 te brengen op EUR 50.375.234,71, door uitgifte van 15.362.656 aandelen ... De vergadering beslist dat de kapitaalverhoging zal worden verwezenlijkt door de inbreng door de enige aandeelhouder van een zekere, vaststaande en opeisbare schuldvordering",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-05-13",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "de conclusies van het verslag van de commissaris de dato 10 mei 2024, opgesteld door de besloten vennootschap \u201CPricewaterhouseCoopers Bedrijfsrevisoren\u201D, te Gent, vertegenwoordigd door de heer Wouter Coppens, in toepassing van de artikelen 7:179, \u00A71, tweede lid en 7:197, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
    "firm_kbo": null,
    "firm_name": "PricewaterhouseCoopers Bedrijfsrevisoren",
    "ibr_number": null,
    "individual_name": "Wouter Coppens"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 50375234.71,
      "delta_eur": 4608796.869999997,
      "before_eur": 45766437.84,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 9999999.9,
      "currency": "EUR",
      "after_eur": 45766437.84,
      "delta_eur": 9999999.9,
      "before_eur": 35766437.94,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-12-21",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 9.999.999,90 EUR, om het van 35.766.437,94 EUR te brengen op 45.766.437,84 EUR, door inbreng in geld",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 45766437.84,
      "delta_eur": 9999999.900000006,
      "before_eur": 35766437.94,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 45766437.84,
      "delta_eur": 9999999.9,
      "before_eur": 35766437.94,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 33333333,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 0.3
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 9999999.9,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-01-31",
    "filing_date": "2024-01-29",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-12-21",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "uitgifte van het proces-verbaal",
    "een volmacht",
    "de geco\u00F6rdineerde tekst van de statuten"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 35766437.94,
      "delta_eur": 3499997.9399999976,
      "before_eur": 32266440.0,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 35766437.94,
      "delta_eur": 3499997.94,
      "before_eur": 32266440.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 11666660,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 0.3
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 3499997.94,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2023-05-17",
    "filing_date": "2023-05-15",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-05-05",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "een uitgifte van het proces-verbaal",
    "\u00E9\u00E9n volmacht",
    "de geco\u00F6rdineerde tekst van de statuten"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 3499997.94,
      "currency": "EUR",
      "after_eur": 35766437.94,
      "delta_eur": 3499997.94,
      "before_eur": 32266440.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-05-05",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 3.499.997,94 EUR, om het van 32.266.440,00 EUR te brengen op 35.766.437,94 EUR, door inbreng in geld",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 10356000.0,
      "delta_eur": 4356000.0,
      "before_eur": 6000000.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 14520000,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 0.3
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 4356000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 14149440.0,
      "delta_eur": 3793440.0,
      "before_eur": 10356000.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "eenige aandeelhouder",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": "schuldvordering",
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 12644800,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 22236440.0,
      "delta_eur": 8087000.0,
      "before_eur": 14149440.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 32566400.0,
      "delta_eur": 10329960.0,
      "before_eur": 22236440.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "kapitalisering_reserves",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2022-10-18",
    "filing_date": "2022-10-14",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2022-10-28",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "PwC Bedrijfsrevisoren BV",
    "ibr_number": null,
    "mission_type": "quasi_apport",
    "individual_name": "Peter Opsomer"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "een uitgifte van het proces-verbaal",
    "\u00E9\u00E9n volmacht",
    "een verslag van het bestuursorgaan",
    "een verslag van de commissaris",
    "de geco\u00F6rdineerde tekst van statuten"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma"
  },
  "legal_form_change": {
    "new": "Naamloze vennootschap",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 32266440,
      "delta_eur": 8149440,
      "before_eur": 24117000,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2022-10-06",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "Conclusies van het verslag van de commissaris de dato 5 oktober 2022, opgesteld door de besloten vennootschap \u201CPricewaterhouseCoopers Bedrijfsrevisoren\u201D, te Culliganlaan 5, 1831 Machelen, vertegenwoordigd door Peter Opsomer, in toepassing van de artikelen 7:179, \u00A71, tweede lid en 7:197, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen, luiden letterlijk als volgt: ... waarvoor wij werden aangesteld bij opdrachtbrief van 4 oktober 2022.",
    "firm_kbo": null,
    "firm_name": "PricewaterhouseCoopers Bedrijfsrevisoren",
    "ibr_number": null,
    "individual_name": "Peter Opsomer"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 4356000,
      "currency": "EUR",
      "after_eur": 28473000,
      "delta_eur": 4356000,
      "before_eur": 24117000,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2022-10-06",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 4.356.000 EUR, om het van 24.117.000 EUR te brengen op 28.473.000 EUR, door inbreng in geld",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 3793440,
      "currency": "EUR",
      "after_eur": 32266440,
      "delta_eur": 3793440,
      "before_eur": 28473000,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2022-10-06",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 3.793.440 EUR om het van 28.473.000 EUR te brengen op 32.266.440 EUR, door inbreng in natura",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "Kortrijksesteenweg 1091 bus B, 9051 Sint-Denijs-Westrem",
        "city": "Sint-Denijs-Westrem",
        "region": "vlaams_gewest",
        "street": "Kortrijksesteenweg",
        "country": "BE",
        "postcode": "9051",
        "box_number": "B",
        "street_number": "1091",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Lembergsesteenweg 25, bus A, 9820 Merelbeke",
        "city": "Merelbeke",
        "region": "vlaams_gewest",
        "street": "Lembergsesteenweg",
        "country": "BE",
        "postcode": "9820",
        "box_number": "A",
        "street_number": "25",
        "locality_suffix": null
      },
      "effective_date": "2022-01-25",
      "evidence_quote": "De bestuurder besluit om de zetel te verplaatsen van Lembergsesteenweg 25a, 9820 Merelbeke, naar Kortrijksesteenweg 1091 bus B, 9051 Sint-Denijs-Westrem, met ingang van heden.",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "act_body",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "immediate",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "Notaris niet vermeld",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2022-01-25",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "enige_bestuurder",
    "date": "2022-01-25",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "Ceres Pharma",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Julie De Craecker",
    "org_rep_person_name": null,
    "person_role_at_subject": "vertegenwoordiging bij administratieve formaliteiten"
  },
  "co_filed_documents": [
    "Bijzondere volmacht voor Julie De Craecker",
    "Formulier voor publicatie in het Belgisch Staatsblad"
  ]
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Sint-Denijs-Westrem",
        "region": null,
        "street": "Kortrijksesteenweg",
        "country": "BE",
        "postcode": "9051",
        "box_number": "B",
        "street_number": "1091"
      },
      "old_address": {
        "city": "Merelbeke",
        "region": null,
        "street": "Lembergsesteenweg",
        "country": "BE",
        "postcode": "9820",
        "box_number": "A",
        "street_number": "25"
      },
      "effective_date": "2022-01-25",
      "evidence_quote": "De bestuurder besluit om de zetel te verplaatsen van Lembergsesteenweg 25a, 9820 Merelbeke, naar Kortrijksesteenweg 1091 bus B, 9051 Sint-Denijs-Westrem, met ingang van heden."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0641.953.324",
    "name_full": "CERES PHARMA",
    "legal_form": "NV"
  }
}